21 May 2025
DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT
Facilitators:
M. Haude, A. Kirtane
Summary
Reflect on the impact of recent trials REC-CAGEFREE 1 and PREVENT on the use of drug-coated balloons (DCB) and preventive PCI for vulnerable plaque. This session includes case discussions highlighting DCB applications and insights from cutting-edge clinical studies.
Learning Objectives
- To reflect about the impact of recent trials on daily practice
- To discuss about the value of DCB in de novo lesions
- To review the current role of preventive PCI for vulnerable plaque